Transplant Diagnostics Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Global Transplant Diagnostics Market size is projected to be valued $XX Billion by 2024; with a CAGR of XX% from 2017 to 2025. Transplantation is the process of relocating organ in order to treat organ failure such as lungs, heart, pancreas, liver and kidney. HLA diagnostic testing is accomplished to determine the tissue compatibility between the donor and recipient in organ and bone marrow transplant.

Major driving factors for this market are raising incidence of chronic diseases, increasing aged population, number of organ transplant procedures, technological advancements and increased R&D activities. However, lack of awareness and organ shortage for transplant procedures are witnessing the growth of the market. Increasing need for organ transplants and growing burden of chronic diseases in emerging nations are creating future opportunities for the transplant diagnostics market.

The transplant diagnostics market is segmented into end user, technology, organ type, application, screening type and geography. On the basis of end user, the transplant diagnostics market is segmented into research laboratories and academic institutions, hospitals and transplant centers and commercial service providers. By organ type, the market is segmented into liver, kidney, heart, pancreas, lung and others. On the basis of technology, transplant diagnostics market is segmented into molecular assay, non-molecular assay and sequencing-based. Furthermore, by screening type the market is segmented into pre-transplant Screening and post-transplant Screening. On the basis of application this market is segmented into research applications and diagnostic applications.

By geography the market is segmented into North America, Europe, Asia-Pacific and RoW. The U.S., Mexico and Canada are covered under North America wherein Europe covers France, Germany, UK, Spain and rest of Europe. Asia-Pacific covers China, India, Japan, South Korea and Rest of Asia Pacific. Rest of the World (RoW) covers South America, Middle East and Africa.

Major players for Transplant diagnostics market are Abbott Laboratories Inc., Qiagen N.V., Illumina, Inc., Linkage Biosciences, Immucor Inc., OlerupSspAb, Thermo Fisher Scientific Inc., Bio- F. Hoffmann-La Roche, Ltd., Sigma-Aldrich, and Rad Laboratories Inc. including others.

The report covers

• The detailed analysis of Transplant Diagnostics Market with respect to key segments such as technology, organ type, screening type, end user, and application has been included in the report
• The report comprises the qualitative and quantitative analysis of the market with market estimation over 2016 – 2025 and CAGR between 2017 and 2025
• Comprehensive analysis of market dynamics including growth factors, restraining factors and opportunities will be provided in the report
• An exhaustive regional and country wise analysis of Transplant Diagnostics Market has been covered in the report
• Profile of the major key players operating in the Transplant Diagnostics Market will be provided, with detailed study on their key financials, product & services, new developments and business strategies

Scope of the Global Transplant Diagnostics Market

Technology Segments

• Molecular assay
• Non-molecular assay
• Sequencing-based

Organ Type Segments

• Liver
• Kidney
• Heart
• Pancreas
• Lung
• Others

Screening Type Segments

• Pre-transplant screening
• Post-transplant Screening

End User Segments

• Research laboratories
• Academic institutions
• Hospitalsand transplant centers
• Commercial service providers.

Application Segments

• Research applications
• Diagnostic applications

Geography Segments

• North America
• U.S.
• Canada
• Mexico

• Europe
• UK
• Germany
• France
• Spain
• Others

• Asia-Pacific
• China
• Japan
• India
• South Korea
• Others
• RoW
• South America
• Middle East
  • Africa